Management of osteoporosis in rheumatoid arthritis patients. - Wikidata - wikimedia - TriplyDB

Management of osteoporosis in rheumatoid arthritis patients.

Management of osteoporosis in rheumatoid arthritis patients.

http://www.wikidata.org/entity/Q38334318

about

Osteoporosis diagnostics in patients with rheumatoid arthritis Evaluating osteoporotic fracture risk with the Fracture Risk Assessment Tool in Chinese patients with rheumatoid arthritis.Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children.Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis.Osteoimmunology and Beyond.The nicotinic acetylcholine receptor α7 subunit is an essential negative regulator of bone mass Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.Application of anti-Sclerostin therapy in non-osteoporosis disease models.Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study.

P2860

Q26741014-C7B39D64-5998-470F-9591-EAECEDC65D1E Q33644108-89929B78-6EB8-4B7B-A510-EB578919C13C Q33749157-DE784805-552E-4F03-8014-7A0FD86ABC2F Q36343783-F4B02C14-F411-45B0-9B28-2F7B870FF3AF Q37181580-B275388C-B4F6-4BD1-BDFD-8B03512B93D8 Q37409538-E94A773B-2327-4F10-9BB6-5E46500691A0 Q37548012-12C3A93D-60B6-4C00-B6A1-7B77A1A4C57B Q37723900-C0FD95B0-D8A0-468A-968C-418E6ED07BFC Q38698132-96D37A4E-CFDF-4785-BFBC-057F242C4756 Q38979293-26F28265-C24A-40C7-8BCA-9246CE98889F Q51363424-520B163D-A5AB-48CD-8C8F-FC79A04FE2D6 Q55405093-5D6846F9-A22E-442A-BD1B-68A53FAF0197

P2860

Management of osteoporosis in rheumatoid arthritis patients.

http://www.wikidata.org/entity/Q38334318

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Management of osteoporosis in rheumatoid arthritis patients.

@en

type

label

Management of osteoporosis in rheumatoid arthritis patients.

@en

prefLabel

Management of osteoporosis in rheumatoid arthritis patients.

@en

P1433

Q38334318-42D2672F-E0EC-4A39-8A6A-F2CD2BE3A66D

P1476

Q38334318-4738ADB8-9A80-4FFC-9BDF-C0DC147F864C

P2093

Q38334318-1739FF36-CC73-455C-8F72-B99A3559AA34

Q38334318-3D540EE3-780A-4F00-B490-6F93602476EC

Q38334318-9CE54BF2-A842-444A-B61C-8551ED83169D

P2860

Q38334318-03463BF4-F0D1-4C42-962E-C94259978E0C

Q38334318-047257CF-E8B6-47F0-BD1C-AD51BAB1A74E

Q38334318-076C5F13-6566-4B35-9791-E5FED41D63EB

Q38334318-0D64AF4C-4089-4906-9036-C2C937267B7E

Q38334318-0EB05C5C-CE41-4CAE-A11A-A0E5B9D663FA

Q38334318-189D3D18-7C99-44EE-AC5B-461A3256125D

Q38334318-1D84F45F-C0BB-4946-88A9-843D7BB2ABEC

Q38334318-21F9CBAA-11EE-46E2-85D8-7374FCF5AE8D

Q38334318-24F38B9B-1A86-44F5-A7A8-E8028B19C848

Q38334318-2BF0C5EB-33FE-408A-83AC-A8A17544800C

P304

Q38334318-91A1A36A-407C-4531-A0F1-B1BB650EFED3

P31

Q38334318-4EA20140-21F8-4BF1-A921-3204711BCE6D

P356

Q38334318-A5DDDE33-53DB-4EF6-AC10-33E9B38B929D

P407

Q38334318-FB1E4D08-B9E1-4EB8-B076-4871F4981F9C

P433

Q38334318-52E57C87-C3FC-46D1-851F-99FF18CC09DB

P478

Q38334318-460ACC7D-C145-4C43-A04F-CF0BE4645F82

P577

Q38334318-F5B6029E-8572-4B93-942F-5446F8058619

P5875

Q38334318-DF390187-7B62-4834-85E3-EE8C4C600C0F

P698

Q38334318-7A0EA6E8-3F2A-45EA-9DD5-2FEF9BA49B04

P921

Q38334318-D9134339-1167-44F1-B8E3-027A104304CF

P356

14656566.2015.997709

P1433

Expert Opinion on Pharmacotherapy

P1476

Management of osteoporosis in rheumatoid arthritis patients.

@en

P2093

Irene E M Bultink

http://www.w3.org/2001/XMLSchema#string

Jos N Hoes

http://www.w3.org/2001/XMLSchema#string

Willem F Lems

http://www.w3.org/2001/XMLSchema#string

P2860

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

The pathogenesis of rheumatoid arthritis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.

Calcium absorption in rheumatoid arthritis

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment

Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis

P304

559-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.997709

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271600645

http://www.w3.org/2001/XMLSchema#string

P698

25626121

http://www.w3.org/2001/XMLSchema#string

P921